Fort Lauderdale, FL, April 30, 2005
edited by Robert N. Weinreb and Jonathan G. Crowston
2005. xiv and 140 pages with 9 tables and 2 figures, of which 1in full color. Hardbound.
ISBN-10: 90 6299 203 X.
Published by Kugler Publications.
Click here for more information on all publications in the Consensus series.
Comment: Although some patients may have a successful result without
adjunctive antifibrosis use, there is no systematic method for identifying these
Comment: Different antifibrotic agents may be associated with different
risks and benefits. MMC may be a more effective adjunct than 5-FU but is associated
Comment: A large antifibrotic treatment area is desirable to achieve
diffuse non-cystic blebs with a lower risk of discomfort and leakage.
Comment: Complications related to the use of antifibrosis agents are
usually related to excessive inhibition of wound healing, which may result in
or prolong early (wound leak, hypotony, shallow anterior chamber, choroidal
detachment, etc.) and late (hyptonony maculopathy, wound leak, and bleb-related
ocular infection, etc.) complications.
Comment: Patients with glaucoma who are undergoing cataract do not necessarily require
combined surgery. To avoid the complications associated with increased postoperative IOP, however, combined procedures should be considered in those patients on multiple
medications or with advanced glaucomatous optic neuropathy.
Comment: Less intense laser therapy on a repeated basis rather than a single high
dose treatment is suggested to minimize complications of treatment.
Don’t miss any WGA news! Subscribe now to the WGA newsletter to stay up to date with all WGA activities.Subscribe